Eyevance Pharmaceuticals Employee Directory
PharmaceuticalsTexas, United States51-200 Employees
Eyevance Pharmaceuticals, founded in 2017 and based in Fort Worth, Texas, is a mid-sized pharmaceutical manufacturer focused on ocular health. It develops and commercializes topical ophthalmic products directed at the ocular surface and anterior segment to support vision and quality of life, with an emphasis on broad patient access across the United States. The company has launched products such as ZERVIATE and TobraDex ST in 2020, and introduced Freshkote PF in 2023. In September 2020 Eyevance was acquired by Santen Holdings U.S. Inc., the U.S. subsidiary of Santen Pharmaceutical Co., Ltd., placing Eyevance within a global ophthalmology-focused company. The Fort Worth operation is supported by a mid-sized workforce, and more information is available at eyevance.com.